Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

A top executive at Novo Nordisk (NVO) warned Tuesday that the company’s diabetes therapy Ozempic will likely be selected for ...

The fund posted returns of 1.89% (Institutional shares) and 1.81% (Investor A shares, without sales charge) for the second ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the formation of ...

They examined six different classes of diabetes medications: DPP4 inhibitors, metformin, SGLT-2 inhibitors, sulfonylureas, alpha-glucosidase inhibitors, and thiazolidinediones. Using a technique ...

An extensive review of 10 studies concluded that alpha-lipoic acid did ... drug interactions with your current list of medications. Ofori SN, Unachukwu CN. Holistic approach to prevention and ...

NervoVive contains antioxidants and anti-inflammatory agents, such as Alpha ... list and consult with a healthcare professional if you have known allergies. Underlying Health Conditions: If you have ...

It has also been used to treat a wide variety of disorders and diseases, including anemia, diabetes, and gastrointestinal issues ... In the United States, the Food and Drug Administration (FDA) does ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...